While various VDR ligands have demonstrated enhanced therapeutic efficacy in experimental models of cancer, inflammation, and cardiovascular disease with evidence of function‐selective and tissue‐selective activities,126 their potential therapeutic applications and underlying molecular mechanisms in different forms of alopecia remain largely unexplored and warrant further investigation. The gene discussed is VDR; the disease is cancer.